col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

211 Results       Page 1

LLC MORION: Rheumatology
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―24 P030 Multiple autoantibody formation post COVID-19 infection Samsul Islam, Nicola Erb
2 [GO] 2024―Apr―24 P001 An audit to assess whether patients who had a delayed or missed denosumab dose during the covid-19 pandemic came to any harm or suffered a subsequent fracture Sumaiya Rehman, Shabina Sultan
3 [GO] 2024―Apr―24 P047 Mortality in patients with rheumatic disease over a three year period encompassing the COVID-19 pandemic: clinically extremely vulnerable status and short form 12 scores are predictive Natasha Cox, James Bateman
4 [GO] 2024―Mar―05 No evidence of increased incidence of ANCA-associated vasculitis following the COVID-19 pandemic: a single-centre experience Elia Touma, Naiel Bisharat
6 [GO] 2024―Mar―02 Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study Leonardo Santos Hoff, R Naveen, Parikshit Sen, Jessica Day, Mrudula Joshi, Arvind Nune, et al. (+47)
7 [GO] 2023―Dec―09 Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study Rathnam K Venkat, Xiaosong Wang, Naomi J Patel, Yumeko Kawano, Abigail Schiff, Emily N Kowalski, et al. (+9)
10 [GO] 2023―Nov―10 Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case-control study Chi Chiu Mok, Chris Ching Lam Cheung, Kar Li Chan, Sau Mei Tse, Chi Hung To
11 [GO] 2023―Sep―26 Correction to: Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
12 [GO] 2023―Aug―24 Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases Marion Thomas, Maeva Masson, Samuel Bitoun, Sabrina Hamroun, Raphaele Seror, Henry Dupuy, et al. (+4)
13 [GO] 2023―Aug―10 E68 Kawasaki Disease before and during COVID-19 R Guedri, A Jelassi, Glai Meriem, H Hrizi, L Essaddam, Z Fitouri, S Ben Becher
14 [GO] 2023―Aug―10 E47 Low prevalence and mortality associated with COVID-19 in sub-Saharan African Children and adolescents: hypotheses from a literature review Fernando Kemta Lekpa, Sylvain Raoul Simeni Njonnou, Dominique Enyama, Diomede Noukeu Njinkui, Jerome Ateudjieu, Henri E Z Tonnang, et al. (+2)
15 [GO] 2023―Aug―10 E44 Differences of hematological abnormalities between COVID-19 infection and multisystemic inflammatory syndrome (MIS-C) M Glai, R Guedri, Z Fitouri, S Ben Becher
16 [GO] 2023―Aug―10 E45 Kawasaki syndrome-related heart disease before and during the COVID-19 pandemic R Guedri, A Jelassi, M Glai, Houcem Hrizi, L Essaddam, Z Fitouri, S Ben Becher
17 [GO] 2023―Aug―02 Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study Ioanna Minopoulou, Koray Tascilar, Giulia Corte, Melek Yalcin Mutlu, Katja Schmidt, Daniela Bohr, et al. (+9)
18 [GO] 2023―Jul―25 COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study Laura Andreoli, Daniele Lini, Karen Schreiber, Ioannis Parodis, Parikshit Sen, R Naveen, et al. (+180)
19 [GO] 2023―Jul―19 Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Konstantinos Mathioudakis, George Konstantonis, Maria G Tektonidou, et al. (+3)
20 [GO] 2023―Jul―11 Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021 Yun-Ting Huang, David A Jenkins, Belay Birlie Yimer, Jose Benitez-Aurioles, Niels Peek, Mark Lunt, et al. (+2)
21 [GO] 2023―Jun―28 Correction to: Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus
22 [GO] 2023―Jun―08 Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients Yusuke Kashiwado, Yasutaka Kimoto, Shiro Ohshima, Takuya Sawabe, Kensuke Irino, Shota Nakano, et al. (+15)
23 [GO] 2023―May―25 Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2 Konstantinos Thomas, Ioannis Grigoropoulos, Panagiota Alexopoulou, Emmanouil Karofylakis, Eirini Galani, Kyriaki Korina Papadopoulou, et al. (+12)
24 [GO] 2023―Apr―24 E086 Comparing ankylosing spondylitis disease activity during the COVID-19 pandemic using patient-reported outcome measures with face-to-face clinical evaluation of disease scores pre-pandemic Dominik A Kurzeja, Kaiyang Song, Maria Mirza, Madiha Ashraf, Lija James, Ayna Verdiyeva, Raashid Luqmani
25 [GO] 2023―Apr―24 E044 Telephone clinic consultations in the COVID-19 era: the rates of conversion to face-to-face appointments and discharges in the post-pandemic years Adlan Wafi Ramli, Xian Hue Ong, Sarang Chitale, Easwaradhas Gladston Chelliah
26 [GO] 2023―Apr―24 E014 Severe myocarditis with cardiogenic shock in adult-onset Still’s disease after mRNA COVID-19 vaccination: a case of atypical presentation Andy Ka Chun Kan, Winnie Wan Yin Yeung, Chak Sing Lau, Philip H Li
27 [GO] 2023―Apr―24 E006 An audit showing the successful operation of a nurse-led gout clinic during the COVID-19 pandemic Lesley-Ann McWilliams, Roger G A Stewart
28 [GO] 2023―Apr―24 E005 An audit of demographics, symptoms & investigations: Part of the survey of GCA in the SEHSCT during the COVID-19 pandemic Han Jun Tan, David Brennan, Claire Masih, Amy Joyce, Blathnaid French
29 [GO] 2023―Apr―24 P059 A review of intra-articular corticosteroid injection safety and clinical effectiveness during COVID-19 Gary J McCall
30 [GO] 2023―Apr―24 P060 A survey of COVID-19 infections in rheumatology patients in Shropshire, UK Ali El Rashid, Raghvendra Prasad Patil, Lisa Burgress, Patrick Ball, Hannah Morrissey, Ayman Askari
31 [GO] 2023―Apr―24 E094 Challenges in the diagnosis and investigation of giant cell arteritis during COVID-19 pandemic restrictions: does the Southend pretest probability score help to guide clinical diagnosis? Jessie Gew, Sarah Loughrey, Maria Wray
32 [GO] 2023―Apr―24 P139 Rituximab in a large UK centre during the COVID-19 pandemic: the effects of employing a reduced dosing regimen on clinical response in Rheumatoid Arthritis patients Joanna McLorinan, Maria Slade, Chi-han Leong, Josie Baker, Lynda Bailey, Jacqueline Nam, et al. (+4)
33 [GO] 2023―Apr―24 E053 Effectiveness of colchicine among patients with COVID-19 infection: a randomised, open labelled, clinical trial Aryan M Jalal, Sheelan Aref, Dashty Albustany
34 [GO] 2023―Apr―24 E054 Rheumatic autoimmune diseases following COVID-19 infection: an observational study in Iraqi Kurdistan Region Aryan M Jalal, Niaz Albarzinji
35 [GO] 2023―Apr―24 E056 C-reactive protein rise in rheumatology patients following COVID-19 vaccination Sung-Hee Kim, Shivani Gor, Khin Yein, Jessica Michael, Elizabeth Price
36 [GO] 2023―Apr―24 P064 Incidence and Clinical Outcomes of New-onset Autoimmune Connective Tissue Diseases after COVID-19 Infection- A Systematic Literature Review Koushan Kouranloo, Mrinalini Dey, Helen Elwell, Arvind Nune
37 [GO] 2023―Apr―24 OA29 Flares following COVID-19 vaccination in patients with idiopathic inflammatory myopathies: combined analysis from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) studies Latika Gupta, R Naveen, Zolten Griger, Vishwesh Agarwal, Parikshit Sen, Mrudula Joshi, et al. (+19)
38 [GO] 2023―Apr―24 E074 Self-care for rheumatoid arthritis during the COVID-19 pandemic: transferability of Canadian and UK experiences James Gavin, Jenny Leese, Smruthi O Ramachandran, Stephanie Therrien, Catherine Backman, Jasmin Ma, et al. (+6)
39 [GO] 2023―Apr―24 P011 Rituximab and COVID-19 vaccines; are they fit for purpose? Sarah K Stewart, Adrian Pendleton
40 [GO] 2023―Apr―24 P103 The impact of the COVID-19 pandemic on primary care referrals and new diagnoses of inflammatory arthritis Ram Bajpai, Claire Burton, Kayleigh J Mason, James Bailey, Kelvin P Jordan, Christian D Mallen, Victoria Welsh
41 [GO] 2023―Apr―24 OA09 Trends for opioid prescriptions and the impact of the COVID-19 pandemic among patients with rheumatic and musculoskeletal diseases between 2006 and 2021 Yun-Ting (Joyce) Huang, David A Jenkins, Belay B Yimer, Jose Benitez-Aurioles, Niels Peek, Mark Lunt, et al. (+2)
42 [GO] 2023―Apr―24 OA19 Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY Mark D Russell, James B Galloway, Colm D Andrews, Brian MacKenna, Ben Goldacre, Amir Mehrkar, et al. (+12)
43 [GO] 2023―Apr―24 P005 Using novel remote electronic monitoring to measure and manage the Rheumatology Clinic backlog generated by COVID-19 Dominik Kurzeja, Anushka Soni, John Jackman, Joel David, Raashid Luqmani
44 [GO] 2023―Apr―24 P051 Development and evaluation of a text-analytics algorithm for automated application of the BSR COVID-19 shielding criteria in rheumatology patients Meghna Jani, Ghada Alfattni, Maksim Belousov, Yuanyuan Zhang, Michael Cheng, Karim Webb, et al. (+3)
45 [GO] 2023―Apr―24 P009 Navigating giant cell arteritis (GCA) service during and post COVID-19 pandemic: an audit of GCA care at North Bristol NHS Trust against the BSR quality standards Kian Wah Lim, Imran Shahriar, Sarah J Villar, Fang En Sin
46 [GO] 2023―Apr―24 P065 Post COVID-19 Syndrome in patients with autoimmune rheumatic diseases: Results from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study Latika Gupta, Parikshit Sen, R Naveen, Mrudula Joshi, Sreoshy Saha, Kshitij Jagtap, et al. (+18)
47 [GO] 2023―Apr―24 P026 Chronic chilblain like lesions associated with the COVID-19 pandemic Joseph A Nathan, Patrick Kiely
48 [GO] 2023―Apr―24 P066 Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients Rhea Suribhatla, Thomas Starkey, Maria C Ionescu, Lennard Y Lee
49 [GO] 2023―Apr―24 P057 Immunosuppression doubles the risk of COVID-19 infection in a large vaccinated cohort of 898 patients with rheumatic diseases: implications for future practice Natasha Cox, James Bateman
50 [GO] 2023―Apr―24 E015 A case of ocular myasthenia gravis seen by rheumatology as suspected mononeuritis multiplex in an adult male shortly after Pfizer-BioNTech SARS-CoV-2 vaccination Alice Storrie, Ryan M Hum, James Lilleker, Pauline Ho
51 [GO] 2023―Apr―24 E040 Disease flare-ups after SARS-CoV-2 vaccination among patients with rheumatic and musculoskeletal diseases in a Rheumatology Specialized Care Center: Sri Lanka Sasheela K Ubhayasiri, Duminda Abeysinghe
52 [GO] 2023―Apr―24 P056 Analysis of antibody response to SARS-CoV-2 vaccination and natural infection in a tertiary centre cohort of lupus nephritis patients Katie Townsend, Andrea Cove-Smith, Ravi Rajakariar, Angela Pakozdi, Myles Lewis, Malvina Cunningham, Debashish Pyne
53 [GO] 2023―Apr―24 E057 A systematic review of new rheumatic immune-mediated inflammatory diseases (R-IMID) following SARS-CoV-2 vaccinations Arvind Nune, Kaustubh Bora, Karthikeyan P Iyengar, Bhupen Barman, Victor Durkowski, Srinivasan Venkatachalam, et al. (+3)
54 [GO] 2023―Apr―24 P062 Immune responses to mRNA vaccines against SARS-CoV2 in patients with immune-mediated inflammatory rheumatic diseases Cristiana Sieiro Santos, Sara Calleja Antolín, Clara Moriano Morales, Carolina Álvarez Castro, Elvira Díez Álvarez, Jose Maria Garcia Ruiz de Morales
55 [GO] 2023―Apr―24 P105 Mode of hospital rheumatology appointments in people with rheumatoid arthritis: the impact of the pandemic in England Ruth E Costello, Rosemary J Hollick, Michael Parker, Jonathan Kennedy, Brian Mackenna, Sinead Brophy, et al. (+2)
56 [GO] 2023―Apr―24 P112 Patient Experience of Remote Healthcare during the Pandemic in Rheumatoid Arthritis and Adult Juvenile Idiopathic Arthritis Rajinder S Andev, Ailsa Bosworth, Clare Jacklin, Shirish Dubey
57 [GO] 2023―Apr―21 Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and 2 surveys R Naveen, Parikshit Sen, Zoltán Griger, Jessica Day, Mrudula Joshi, Arvind Nune, et al. (+181)
58 [GO] 2023―Apr―05 COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project Megan Rutter, Peter C Lanyon, Matthew J Grainge, Richard Hubbard, Mary Bythell, Peter Stilwell, et al. (+4)
59 [GO] 2023―Apr―02 Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study Sasha Saadia Ali, Naveen R, Parikshit Sen, Jessica Day, Mrudula Joshi, Arvind Nune, et al. (+180)
60 [GO] 2023―Jan―20 COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases Joo Guan Yeo, Kai Liang Teh, Wan Ni Chia, Yun Xin Book, Sook Fun Hoh, Xiaocong Gao, et al. (+12)
61 [GO] 2023―Jan―14 COVID-19 admissions and mortality in patients with early inflammatory arthritis: Results from a UK national cohort Maryam A Adas, Mark D Russell, Emma Cook, Edward Alveyn, Jennifer Hannah, Sathiyaa Balachandran, et al. (+5)
63 [GO] 2022―Dec―20 SARS-CoV-2 Vaccine Immunogenicity in Patients with Autoimmune Inflammatory Rheumatic Diseases Victoria Furer
64 [GO] 2022―Dec―19 COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes Chung M A Lin, Josh Bennett, Lavanya Rajagopala, Ewan Hunter, Alice R Lorenzi, Bridget Griffiths, Kenneth F Baker
65 [GO] 2022―Nov―28 Rituximab-treated rheumatic patients: B-cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders Christian Ammitzbøll, Marianne Kragh Thomsen, Jakob Bøgh Andersen, Jens Magnus Berth Jensen, Marie-Louise From Hermansen, Anders Dahl Johannsen, et al. (+8)
66 [GO] 2022―Nov―22 Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study Naveen R, Elena Nikiphorou, Mrudula Joshi, Parikshit Sen, Julius Lindblom, Vishwesh Agarwal, et al. (+105)
67 [GO] 2022―Nov―10 COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies Laura Andreoli, Parikshit Sen, Daniele Lini, Melinda Nagy Vincze, Karen Schreiber, Naveen R, et al. (+180)
68 [GO] 2022―Oct―31 COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis Naveen R, Ioannis Parodis, Mrudula Joshi, Parikshit Sen, Julius Lindblom, Vishwesh Agarwal, et al. (+102)
69 [GO] 2022―Oct―25 Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still’s disease Xinyue Hong, Haoyu Pan, Yutong Su, Qiongyi Hu, Yue Sun, Honglei Liu, et al. (+19)
70 [GO] 2022―Oct―21 COVID-19 vaccination in systemic lupus erythematosus: a systematic review for effectiveness, immunogenicity, flares and acceptance Shaun Ye Song Tan, Aaron Mingyang Yee, Jackie Jia Lin Sim, Cynthia Ciwei Lim
71 [GO] 2022―Oct―17 Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination Leher Gumber, Nancy Gomez, Georgina Hopkins, Davis Tucis, Laura Bartlett, Kieran Ayling, et al. (+13)
72 [GO] 2022―Oct―07 69 Large vessel vasculitis occurring after COVID-19 infection: 2 Takayasu cases Vafa Guliyeva
73 [GO] 2022―Oct―04 Comment on: COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
74 [GO] 2022―Sep―20 Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status Sinead Maguire, Samar Al-Emadi, Paula Alba, Mathia Cecilia Aguiar, Talal Al Lawati, Gelsomina Alle, et al. (+58)
75 [GO] 2022―Sep―20 Transient osteoporosis of the hip: a novel vascular manifestation of COVID-19? Jacopo Ciaffi, Elena Vanni, Giancarlo Facchini, Marco Miceli, Francesco Ursini
76 [GO] 2022―Sep―07 COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort Christopher McMaster, David F L Liew, Susan Lester, Adam Rischin, Rachel J Black, Vibhasha Chand, et al. (+6)
77 [GO] 2022―Sep―01 Is vaccination against Covid-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis Georgina Nakafero, Matthew J Grainge, Tim Card, Christian D Mallen, Jonathan S Nguyen Van-Tam, Hywel C Williams, Abhishek Abhishek
78 [GO] 2022―Aug―24 Seroconversion after a third COVID-19 vaccine is affected by rituximab dose but persistence is not in patients with rheumatoid arthritis Céleste J T van der Togt, David F Ten Cate, Bart J F van den Bemt, Janette Rahamat-Langendoen, Nathan den Broeder, Alfons A den Broeder
79 [GO] 2022―Aug―16 Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus Simone Cosima Boedecker-Lips, Paul Claßen, Daniel Kraus, Julia Weinmann-Menke
80 [GO] 2022―Aug―03 Different Covid-19 Outcomes Among Systemic Rheumatic Diseases: A Nation-wide Cohort Study Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Konstantinos Mathioudakis, Anastasios Tsolakidis, George Konstantonis, et al. (+5)
81 [GO] 2022―Aug―03 Effectiveness of the BNT162b2 mRNA COVID-19 Vaccine among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases Amit Ziv, Merav Heshin-Bekenstein, Ruby Haviv, Shaye Kivity, Doron Netzer, Shlomit Yaron, et al. (+6)
82 [GO] 2022―Aug―02 SARS-CoV-2 vaccinations in children and adolescents with rheumatic diseases Ethan S Sen, Dalila Julandani, Athimalaipet V Ramanan
83 [GO] 2022―Jul―22 COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary antiphospholipid syndrome: a prospective study Haoyu Pan, Zihan Tang, Jialin Teng, Yue Sun, Honglei Liu, Xiaobing Cheng, et al. (+18)
84 [GO] 2022―Jul―05 Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors Dimitra Dimopoulou, Maria N Tsolia, Nikos Spyridis, Despoina N Maritsi
85 [GO] 2022―Jun―27 Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series Mayan S Teles, Caoilfhionn M Connolly, Rachel Wallwork, Sarah Frey, Teresa Po-Yu Chiang, Jennifer L Alejo, et al. (+5)
86 [GO] 2022―Jun―23 Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis Sara Monti, Chiara Fornara, Paolo Delvino, Alice Bartoletti, Federica Bergami, Giuditta Comolli, et al. (+7)
87 [GO] 2022―Jun―22 A rare onset in tumor necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection Şengül Çağlayan, Kadir Ulu, Mustafa Çakan, Betül Sözeri
88 [GO] 2022―Jun―17 COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study Parikshit Sen, Naveen R, Arvind Nune, James B Lilleker, Vishwesh Agarwal, Sinan Kardes, et al. (+23)
89 [GO] 2022―Jun―01 Risk of systemic vasculitis following mRNA COVID-19 vaccination: a pharmacovigilance study Camille Mettler, Benjamin Terrier, Jean-Marc Treluyer, Laurent Chouchana
90 [GO] 2022―May―31 Strong response after 4th dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine Nadia E Aikawa, Leonard V K Kupa, Clovis A Silva, Carla G S Saad, Sandra G Pasoto, Emily F N Yuki, et al. (+13)
91 [GO] 2022―May―31 Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis Rebecca B Blank, Rebecca H Haberman, Kun Qian, Marie Samanovic, Rochelle Castillo, Anthony Jimenez Hernandez, et al. (+14)
92 [GO] 2022―May―24 COVID-19 mRNA vaccine booster in patients with autoimmune rheumatic diseases Chiara Cardelli, Teresita Caruso, Chiara Tani, Federico Pratesi, Rosaria Talarico, Federica Di Cianni, et al. (+9)
93 [GO] 2022―May―18 Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease Caoilfhionn M Connolly, Sarah Frey, Teresa Po-Yu Chiang, Mayan Teles, Jennifer L Alejo, Jemima Albayda, et al. (+5)
94 [GO] 2022―Apr―25 P014 Giant Cell Arteritis Patient Pathway: A Multi-Disciplinary Approach to Service Improvement in the time of COVID-19 Ben Mulhearn, Jessica Ellis, Sarah Smith, Sarah L Tansley, Sarah Skeoch
95 [GO] 2022―Apr―25 OA02 A cohort of 79 children with Paediatric multisystem inflammatory syndrome associated with COVID-19 Marek Bohm, Tania Amin, Antigoni Deri, Kapil Gargh, Mark Wood
96 [GO] 2022―Apr―25 P071 A case series of rheumatic disease patients diagnosed with COVID-19 Feb 2020 to March 2021 at the hospital that reported London’s index case of COVID-19 James Pilcher, Ghada Yanni, Pamela Lutalo, Louise Pollard
97 [GO] 2022―Apr―25 P059 Acceptability of remote consulting during COVID-19 among patients with two common long-term musculoskeletal conditions: findings from three qualitative studies and recommendations for practice Zoe Paskins, Laurna Bullock, Fay Manning, Simon Bishop, Paul Campbell, Elizabeth Cottrell, et al. (+5)
98 [GO] 2022―Apr―25 OA05 Lower incidence of COVID-19 but higher mortality in patients with inflammatory arthritis compared to controls in Wales, United Kingdom: a population epidemiological study Roxanne Cooksey, Jonathan Underwood, Sinead Brophy, Mark Atkinson, Jonathan Kennedy, Ernest Choy
99 [GO] 2022―Apr―25 P074 Evaluation of incidence of COVID-19 infection and uptake of COVID-19 vaccine in sarcoidosis patients at a tertiary centre Deepak Nagra, Shannon A Gunawardana, Katie Bechman, Surinder Birring, Amit Patel, James Galloway
100 [GO] 2022―Apr―25 P070 Patients with idiopathic inflammatory myopathies suffer from poor self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort Rajat Kharbanda, Keya Ganatra, Vikas Agarwal, Latika Gupta
101 [GO] 2022―Apr―25 P111 Patient-related factors influencing remote consultations in rheumatology - lessons from a COVID-19 initiative Michael Hannides, Surabhi Wig, Sreekanth Vasireddy
102 [GO] 2022―Apr―25 P112 Impact of technical factors on remote consultations in rheumatology - lessons from a COVID-19 initiative Sreekanth Vasireddy, Surabhi Wig, Michael Hannides
103 [GO] 2022―Apr―25 P064 Impact of COVID-19 on physical and mental health of people with inflammatory conditions: the ICEPAC survey Samantha Hider, Sara Muller, Lauren Gray, Fay Manning, Mike Brooks, Dominic Heining, et al. (+7)
104 [GO] 2022―Apr―25 P302 Trends in hospital admissions in patients with ANCA-associated vasculitis before and during the COVID-19 pandemic Myron Odingo, Megan Rutter, Peter Lanyon, Matthew Grainge, David Groves, Mary Bythell, et al. (+3)
105 [GO] 2022―Apr―25 P068 Monitoring of methotrexate blood toxicity during the COVID-19 pandemic for patients with rheumatoid arthritis: data from the Greater Manchester Care Record Ruth E Costello, Richard Williams, Ian N Bruce, Kimme Hyrich, William G Dixon, Jenny H Humphreys
106 [GO] 2022―Apr―25 OA03 Impact of the COVID-19 pandemic on rheumatology training: results of the regional survey from the North West of England Ezolene P Chua, Yvonne Tan, Louise K Mercer, Surabhi Wig
107 [GO] 2022―Apr―25 P019 Rheumatology Referrals to Tertiary Care Hospital over a Three Month Period During Covid-19 Pandemic: a Quality Improvement Project Behram Khan, Trixy David, Caroline Clegg, Benjamin Parker
108 [GO] 2022―Apr―25 P073 Patient with rheumatoid arthritis on regular rituximab infusions with severe COVID-19 pneumonitis despite both vaccinations Nasreen Abdullah, Alison Kinder, David Jenkins, Veena Patel
109 [GO] 2022―Apr―25 P072 Audit on the uptake of COVID-19 vaccination in biologic patients with autoimmune conditions Benedict Osei-Boadu, Gurdas Singh-Rathore, Sunitha Achandil, Gouri M Koduri
110 [GO] 2022―Apr―25 P065 Post COVID-19 vaccination inflammatory arthritis: a case series of patients at a district general hospital Sarah E Fordham, Katerina M Achilleos, Shweta S Bhagat, Mark P Sykes
111 [GO] 2022―Apr―25 P237 New-onset systemic lupus erythematosus following COVID-19 vaccination: a report of two cases James Beynon, Michael Alsharkawy, Luke Sammut, Joanna Ledingham
112 [GO] 2022―Apr―25 P061 Polymyalgia rheumatica following COVID-19 vaccination: presentation of four patients Marwa Mohareb, Anurag Bharadwaj, Anupama Nandagudi
113 [GO] 2022―Apr―25 P020 The impact of COVID-19: local observations from the National Early Inflammatory Arthritis Audit Elizabeth MacPhie, Lesley Ashcroft, Nicola Foreman, Sharon GIlbert, Sarah Horton, Ayesha Madan, et al. (+3)
114 [GO] 2022―Apr―25 P194 Flares of rheumatoid arthritis following coronavirus vaccination Rhys J Hayward, Ziad Farah
115 [GO] 2022―Apr―25 OA43 Development of a national across specialty multi-disciplinary team for management of hyper-inflammatory conditions during the SARS-CoV-2 pandemic Kirsty McLellan, Liam Reilly, Louisa Pollock, Olivia Swann, Catriona Anderson, Neil Martin, et al. (+3)
116 [GO] 2022―Apr―25 OA01 Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, Elsa Mateus, Kimme Hyrich, Laure Gossec, et al. (+25)
117 [GO] 2022―Apr―25 P166 Working in partnership with the third sector to provide support for paediatric, adolescent patients and families throughout COVID-19 and beyond Klaire Connor
118 [GO] 2022―Apr―25 P053 Heterotopic ossification after COVID-19 infection - case report Yvonne Chang, Eleni Stathopoulou
119 [GO] 2022―Apr―25 OA06 Single-centre experience of the use of Rituximab for inflammatory arthritis during the COVID-19 pandemic James Kimpton, Chloe Bradbury, Rhys Gravell, Samantha Moore, Pauline Buck, Maria Leandro
120 [GO] 2022―Apr―25 P017 Variations in clinical practice in paediatric rheumatology units as a result of the COVID-19 pandemic: Initial findings of a UK wide Multi-Centre Survey Diarmuid McLaughlin, Samundeeswari Deepak
121 [GO] 2022―Apr―25 P193 How did people with rheumatoid arthritis experience the COVID-19 pandemic? Interim qualitative results from the BIORA-PAIN study Anna Blundell, Gill Mein, Soraya Koushesh, Adangebe Omoruyi, Abiola Harrison, Philip Sedgwick, Nidhi Sofat
122 [GO] 2022―Apr―25 P069 A phone survey on the acceptance of COVID-19 vaccination amongst adolescents in a rheumatology centre in Malaysia Chun Ruh Ng, Tze Hau Ho
123 [GO] 2022―Apr―25 P076 Innovative SMS based COVID-19 vaccination video advice: real-world evidence of the positive impact on vaccination uptake in a large single-centre cohort Harsh Khatri, Natasha Cox, Lavanya Rajagopala, James Bateman
124 [GO] 2022―Apr―25 P154 Parents report that healthcare professionals play an influential role in deciding whether to vaccinate against COVID-19: results of a patient-led survey in Canada Jennifer Wilson, Wendy Costello, Saskya Angevare, Richard P Beesley
125 [GO] 2022―Apr―25 P060 Living with rheumatoid arthritis during the coronavirus pandemic: a longitudinal interview study Paul Campbell, Zoe Paskins, Samantha Hider, Andrew Hassell, Fay Crawford-Manning, Katrina Rule, et al. (+2)
126 [GO] 2022―Apr―25 P155 Implementing change in treatment delivery for children and young people during a pandemic Ruth Wyllie
127 [GO] 2022―Apr―25 P021 Development of a Rheumatology Hot Clinic in the Midst of a Pandemic Asim Khan, Clarissa Murdoch, Ihuoma Wamuo
129 [GO] 2022―Apr―13 COVID-19 infection and hospitalisation risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis René Cordtz, Salome Kristensen, Rasmus Westermann, Kirsten Duch, Fiona Pearce, Jesper Lindhardsen, et al. (+3)
130 [GO] 2022―Apr―12 Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome: a nationwide survey Vittorio Pengo, Teresa Del Ross, Marta Tonello, Laura Andreoli, Angela Tincani, Paolo Gresele, et al. (+11)
131 [GO] 2022―Apr―04 Autoimmune disease and COVID-19- a multicentre observational study in the United Kingdom Deepa J Arachchillage, Indika Rajakaruna, Charis Pericleous, Philip L R Nicolson, Mike Makris, Mike Laffan, et al. (+393)
132 [GO] 2022―Apr―04 Humoral response to Coronavirus Disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis Céleste J T van der Togt, David F Ten Cate, Nathan den Broeder, Janette Rahamat-Langendoen, Bart J F van den Bemt, Alfons A den Broeder
133 [GO] 2022―Mar―29 Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection Jérôme Avouac, Roba Ghossan, Omar Al Tabaa, Alice Combier, Alexia Steelandt, Marion Thomas, et al. (+7)
134 [GO] 2022―Mar―22 An uncomfortable truth: the long-term impact of Covid-19 on the clinician-patient relationship Megan Rutter, Fiona A Pearce, Peter C Lanyon
135 [GO] 2022―Mar―12 Correction to: Increased incidence of anti-synthetase syndrome during COVID-19 pandemic Bethan Phillips, James Martin, Ceril Rhys-Dillon
136 [GO] 2022―Mar―01 Safety of the BNT162b2 mRNA COVID-19 vaccine in patients with familial Mediterranean fever Liran Shechtman, Karney Lahad, Avi Livneh, Chagai Grossman, Amit Druyan, Eitan Giat, et al. (+6)
137 [GO] 2022―Feb―21 Robust neutralising antibody response to SARS-CoV-2 mRNA vaccination in adolescents and young adults with childhood onset rheumatic diseases Joo Guan Yeo, Wan Ni Chia, Kai Liang Teh, Yun Xin Book, Sook Fun Hoh, Xiaocong Gao, et al. (+14)
138 [GO] 2022―Feb―16 Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications Merav Heshin-Bekenstein, Amit Ziv, Natasa Toplak, David Hagin, Danielle Kadishevich, Yonatan A Butbul, et al. (+7)
140 [GO] 2021―Dec―14 Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-center study Giuseppe A Ramirez, Marco Lanzillotta, Mikael Ebbo, Andreu Fernandez-Codina, Gaia Mancuso, Olimpia Orozco-Galvez, et al. (+5)
141 [GO] 2021―Dec―08 SARS-CoV-2 vaccine in patients with systemic sclerosis: Impact of disease subtype and therapy Percival Degrava Sampaio-Barros, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino-Assad, Renata Miossi, Henrique Carriço da Silva, Emily F V N Yuki, et al. (+8)
142 [GO] 2021―Dec―06 A deeper dive into rare autoimmune diseases, death and COVID-19 in the first wave of the pandemic Marwan Bukhari
143 [GO] 2021―Nov―11 O005. Telemedicine in Juvenile Idiopathic Arthritis in the era of COVID-19 Makhlouf Yasmine, Ben Nessib Dorra, Maatallah Kaouther, Ferjani Hanene, Triki Wafa, Kaffel Dhia, Hamdi Wafa
144 [GO] 2021―Nov―11 P078 Multi-system inflammatory syndrome associated with SARS-CoV-2 in children: clinical and therapeutic characteristics Nacera Masmi
145 [GO] 2021―Oct―08 Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study Camille Mettler, Annie-Pierre Jonville-Bera, Aurélie Grandvuillemin, Jean-Marc Treluyer, Benjamin Terrier, Laurent Chouchana
146 [GO] 2021―Oct―07 Behçet's-like adverse event or inaugural Behçet's disease after SARS-CoV-2 mRNA-1273 vaccination? Florian Tagini, Lionel Carrel, Benedict Fallet, David Gachoud, Camillo Ribi, Matteo Monti
147 [GO] 2021―Sep―30 Seroprevalence and Clinical Outcomes of SARS-CoV-2 in Paediatric Patients with Rheumatic Disease Heather M Walters, Zanab Mian, Lydia Thomas, Jane Cerise, B Anne Eberhard, Eileen Pagano, et al. (+3)
148 [GO] 2021―Aug―04 Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic Matteo Piga, Alberto Floris, Mattia Congia, Elisabetta Chessa, Ignazio Cangemi, Alberto Cauli
149 [GO] 2021―Aug―04 Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, Francesca Pregnolato, Francesco Tamborini, Paolo Miraglia, et al. (+5)
150 [GO] 2021―Jul―27 THE ROLE OF CHEST CT IN DECIPHERING INTERSTITIAL LUNG INVOLVEMENT: SYSTEMIC SCLEROSIS VERSUS COVID-19 Martina Orlandi, Nicholas Landini, Gianluca Sambataro, Cosimo Nardi, Lorenzo Tofani, Cosimo Bruni, et al. (+39)
151 [GO] 2021―Jul―21 Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever Fadi Kharouf, Yuval Ishay, Ariel Kenig, Menachem Bitan, Eldad Ben-Chetrit
153 [GO] 2021―Jun―17 Impact of the COVID-19 pandemic on treat to target strategies and physical consultations in > 7000 patients with inflammatory arthritis Bente Glintborg, Dorte Vendelbo Jensen, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, Mikkel Østergaard, et al. (+15)
154 [GO] 2021―Jun―07 Corrigendum to: Focal small bowel thrombotic microvascular injury in COVID-19 mediated by the lectin complement pathway masquerading as lupus enteritis Benjamin Plotz, Rochelle Castillo, Jonathan Melamed, Gerard Nuovo, Cynthia Magro, Pamela Rosenthal, H Michael Belmont
155 [GO] 2021―May―13 Empathic communication during a pandemic: How can we minimise the deficit? Marwan Bukhari, Sandra Robinson, Ade Adebajo, Peta Heslop, David Walker
156 [GO] 2021―May―12 Cluster analysis reveals 3 main patterns of behavior towards SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases Renaud Felten, Maxime Dubois, Manuel Francisco Ugarte-Gil, Aurore Chaudier, Lou Kawka, Hugo Bergier, et al. (+10)
157 [GO] 2021―Apr―26 P068 Early experience and outcomes of telephone and video consultations in rheumatology during first wave of COVID-19 Chandini Rao, Sarah Horton, Elizabeth MacPhie, Ayesha Madan, Sarah Fish
158 [GO] 2021―Apr―26 P113 How has COVID-19 affected the treatment of osteoporosis? The answers from a global survey Nicholas R Fuggle, Andrea Singer, Nicholas Harvey, Jean-Yves Reginster, Cyrus Cooper, Susan Greenspan
159 [GO] 2021―Apr―26 O21 The incidence of COVID-19 among children with rheumatic diseases receiving biological agents Nadezhda Tsurikova, Elena Ligostaeva, Vadim Avdeenko, Nataliya Kobzeva, Irina Tsiganok, Karina Skorobogatova, Anastasia Motkina
160 [GO] 2021―Apr―26 P055 Worry about COVID-19 amongst adult rheumatology patients in the UK is associated with the number of cases, and drives risk-reducing behaviours Richard P Beesley, Wendy Costello, Saskya P Angevare, Yosef Uziel, Carine Wouters, Nico Wulffraat
161 [GO] 2021―Apr―26 P021 Rheumatology shielded patients, hospitalised COVID-19 and outcomes in Essex: an audit across Mid and South Essex and Barking, Havering and Redbridge Hospitals NHS Trusts Chavini Ranasinghe, Anupama Nandagudi, Emese Balogh, Emerald Sekaran, Teresa Doherty, Akmol Ali, et al. (+2)
162 [GO] 2021―Apr―26 P058 Persistence of neutrophil abnormalities in COVID-19 convalescence Thomas O Williams, Verena Kästele, Elizabeth R Mann, Sean B Knight, Madhvi Menon, Christopher Jagger, et al. (+18)
163 [GO] 2021―Apr―26 O31 Trajectories of anxiety in children young people and adults with rheumatic diseases in the wake of COVID-19: results from the COVID-19 European patient registry Stephanie J W Shoop-Worrall, Suzanne M M Verstappen, Wendy Costello, Saskya P Angevare, Yosef Uziel, Carine Wouters, et al. (+2)
164 [GO] 2021―Apr―26 O23 Testing the waters: COVID-19 first wave and shielding among Black, Asian and Minority Ethnic patients with rheumatological conditions in the UK Shirish Dubey, Kanta Kumar, Helen Bunting, Tom Sheeran, Barbara Douglas, Jessy Sabu, et al. (+2)
165 [GO] 2021―Apr―26 P095 The impact of COVID-19 lockdown on clinical care, self-management, and mental health in patients with inflammatory arthritis Melissa Sweeney, Lewis Carpenter, Savia de Souza, Hema Chaplin, Hsiu Tung, Emma Caton, et al. (+4)
166 [GO] 2021―Apr―26 O20 Initial impact of COVID-19 on health-related quality of life in patients with rheumatic diseases from an evaluation of 1,727 patients: BAME and female patients are at higher risk Natasha Cleaton, James Bateman
167 [GO] 2021―Apr―26 O22 Evaluating the impact of COVID-19 on patient access to rheumatology services, medication and future care: a nationwide study of more than 2,000 patients Chris Wincup, Raj Amarnani, Ian Giles
168 [GO] 2021―Apr―26 O30 Variation in immunosuppressant impact on severe COVID-19 outcome: preliminary results from the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19) Maira Karabayas, James Brock, Matthew Rutherford, Gillian Fordyce, Nick Fluck, Sally Kardash, et al. (+14)
169 [GO] 2021―Apr―26 P061 Patient experience of telephone helpline service during the COVID-19 pandemic Aneela T Devarakonda, Shaza Obaid, Chakameh Faqihinejad
170 [GO] 2021―Apr―26 P071 Survey of rheumatology patient satisfaction with telephone consultations during the COVID-19 pandemic Mia Rodziewicz, Terence O'Neill, Audrey Low
171 [GO] 2021―Apr―26 P204 An evaluation of a daily fast-track diagnostic ultrasound service for patients with suspected new onset giant cell arteritis during the COVID-19 pandemic Jonathan P White, Germana Sallemi, Binaya Dhungana, Shirish Dubey, Raashid A Luqmani
172 [GO] 2021―Apr―26 P120 Self-reported disease activity was the main determinant of the perceived impact of COVID-19 pandemic on adolescent and young patients with juvenile dermatomyositis (JDM) and juvenile onset systemic lupus erythematosus (JSLE) Ayesha Khatun, Wing Han Wu, Junjie Peng, Laura Hennelly, Melanie Sloan, Michael Bosley, et al. (+3)
173 [GO] 2021―Apr―26 P059 Wellbeing and shielding of patients with rheumatic disease on biologic therapy during the early COVID-19 pandemic: a single centre experience Lucy M Carter, Hannah Irvine, Adnan D’Cunha Kamath, Ankita Sahni, Patrick Hanna, Naim Rahimi, Kuljeet Bhamra
174 [GO] 2021―Apr―26 P028 Aortic thrombosis with persistently positive antiphospholipid antibodies in a patient with COVID-19 pneumonitis Maja Curuvija, Kim Hawkins, Shibeb Al-Mudhaffer, Emyr P M Humphreys
175 [GO] 2021―Apr―26 P007 Service evaluation of the nurse-led telephone advice line in the wake of COVID-19: a report of audit and staff satisfaction Julia Day, Janet Ball, Jayne Down, Raj Sengupta
176 [GO] 2021―Apr―26 P005 Rheumatology virtual clinics during COVID-19: are our patients satisfied? Fajer A Altamimi, Una Martin
177 [GO] 2021―Apr―26 P053 Fulminant purpura in a patient with SARS-CoV-2 Nadezhda Tsurikova, Svatlana Rodionocskaya, Elena Ligostaeva, Vadim Avdeenko, Nataliya Kobzeva, Irina Tsiganok
178 [GO] 2021―Apr―26 P057 What is the course of SARS-CoV-2 infection in people with autoimmune conditions on immunomodulators in comparison to people without autoimmune disease? Kathryn Biddle, Soraya Koushesh, David Clark, Sanjeev Krishna, Shannon Webb, Kamal Patel, et al. (+2)
179 [GO] 2021―Apr―26 P140 As we move to using short-acting drugs for the treatment of RA in the time of a pandemic, does baricitinib live up to its trial data in clinical practice? Henry J S Vardon, Karen M J Douglas
180 [GO] 2021―Apr―26 P051 Symptoms of COVID-19 and anxiety levels in adult patients receiving b-and ts-DMARDS using an online reporting system May Nwe Lwin, Christopher Holroyd, Dinny Wallis, Saul Faust, Hans De Graaf, Christopher J Edwards
181 [GO] 2021―Apr―26 P054 Risk of death during the 2020 UK COVID-19 epidemic among people with rare diseases compared to the general population Megan Rutter, Peter C Lanyon, Emily Peach, Matthew J Grainge, Richard B Hubbard, Jeanette Aston, et al. (+3)
182 [GO] 2021―Apr―26 O24 Risk of death during the 2020 UK COVID-19 epidemic and annual influenza seasons among people with vasculitis compared to the general population: a whole-population study using data from the NDRS and the RECORDER project Megan Rutter, Peter C Lanyon, Matthew J Grainge, Richard B Hubbard, Emily J Peach, Mary Bythell, et al. (+3)
183 [GO] 2021―Apr―26 P049 Skeletal muscle involvement in COVID-19 infection: a case report and systematic review Jennifer R Hannah, Sasha Saadia Ali, James Galloway, Patrick Gordon
184 [GO] 2021―Apr―26 O25 The impact of COVID-19 lockdown on mental health and quality of life in patients with inflammatory arthritis Melissa Sweeney, Lewis Carpenter, Savia de Souza, Hema Chaplin, Hsiu Tung, Emma Caton, et al. (+4)
185 [GO] 2021―Apr―26 P068 Exploring the impact of COVID-19 on self-management and healthcare provision in people with Inflammatory Arthritis: A qualitative study Emma Caton, Hema Chaplin, Lewis Carpenter, Melissa Sweeney, Hsiu Tung, Savia de Souza, Sam Norton
186 [GO] 2021―Apr―26 P052 Leflunomide and severe COVID-19 outcome: a cautionary observation from the COVID-19 Scottish Registry of Autoimmune Rheumatic Diseases (SCAR-19) Maira Karabayas, James Brock, Gillian Fordyce, Neil Basu
187 [GO] 2021―Apr―26 P072 Tele-rheumatology: outcomes from the COVID-19 pandemic Samir Patel, Pamela Lutalo, Ghada Yanni, Louise Pollard
188 [GO] 2021―Apr―26 P032 Increased incidence of anti-synthetase syndrome during COVID-19 pandemic Bethan Phillips, James Martin
189 [GO] 2021―Apr―26 P064 The impact of the COVID-19 pandemic on outpatient services: an analysis of patient feedback of virtual outpatient clinics in a tertiary teaching centre with a focus on musculoskeletal and rheumatology services Swetha Byravan, Kehinde Sunmboye
190 [GO] 2021―Apr―26 P075 Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study Marco Garrido-Cumbrera, Victoria Navarro-Compán, Dale Webb, Clare Jacklin, Shantel Irwin, Laura Christen, et al. (+3)
191 [GO] 2021―Apr―26 P069 Results of an online survey exploring the effects of shielding during the COVID-19 pandemic on patients with spondyloarthritis (SpA) Meena Naja, Raj Amarnani, Madhura Castelino
192 [GO] 2021―Apr―26 P065 The road to recovery: developing a new service for urgent face-to-face rheumatology outpatient appointments during the COVID-19 pandemic: a single centre experience Chris Wincup, Raj Amarnani, Sarina Rana, Jaclyn Tan, Filipa Farinha, Su-Ann Yeoh, et al. (+2)
193 [GO] 2021―Apr―26 P135 Delivering a rheumatoid arthritis remote monitoring service during the COVID-19 pandemic: the patient's perspective Melanie J Martin, Toby Garrood
194 [GO] 2021―Apr―26 P082 Virtual undergraduate rheumatology teaching: a viable alternative approach during the COVID-19 pandemic? Prince Jiju, Katy Boyce, Kavitha Nadesalingam
195 [GO] 2021―Apr―26 P050 Influence factors in mortality of COVID-19 pateints with underlying rheumatological disorders Wint W Soe, Farida Hassan, Wah Phyu
196 [GO] 2021―Apr―26 P076 Adherence to COVID-19 risk stratification during the peak of pandemic: a District General Hospital experience Salma Azam, Eils Thompson, Natalie Costello, Ashar Ahmed, Arvind Nune, Hamza Ahmed
197 [GO] 2021―Apr―26 P056 Recurrent ACE-inhibitor induced angioedema in a patient with long COVID-19 syndrome Helena Crawshaw, Stuart Webber
198 [GO] 2021―Apr―26 P042 A rare case of constrictive pericarditis with co-existing positive COVID-19: probable autoimmune or immunoglobulin related disease Ziad Alkutobi, Ghazal Ansari, Anupama Nandagudi
199 [GO] 2021―Apr―26 P062 How do our patients feel about face-to-face review in rheumatology clinics since COVID-19? A single tertiary care centre experience Raj Amarnani, Bethan Goulden, Jessica Manson, Vanessa Morris
200 [GO] 2021―Apr―26 P073 Interactive rheumatology biologic self-injection video advice using an SMS based video resource: successful implementation during a pandemic Pritesh Mistry, James Bateman, Kay Hughes
201 [GO] 2021―Apr―26 P070 Tele-consultations from the patient’s perspective: during the pandemic and beyond Natasha Cleaton, Sabrina Raizada
202 [GO] 2021―Apr―23 Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal? Rheumatology (Oxford). 2021;60:1585-1587 Sujoy Khan
203 [GO] 2021―Apr―13 Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy Stefania Spila Alegiani, Salvatore Crisafulli, Paolo Giorgi Rossi, Pamela Mancuso, Carlo Salvarani, Fabiola Atzeni, et al. (+10)
204 [GO] 2021―Mar―20 Onset of dermatomyositis in close association with COVID-19 - a first case reported Nicolas Henrique Borges, Thiago Mateus Godoy, Bárbara Stadler Kahlow
205 [GO] 2021―Mar―10 COVID-19 vaccination and antirheumatic therapy Jack Arnold, Kevin Winthrop, Paul Emery
206 [GO] 2021―Feb―18 Timing of Rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis Luca Quartuccio, Elena Treppo, Marco Binutti, Giulia Del Frate, Salvatore De Vita
207 [GO] 2021―Feb―13 Survey of adult and paediatric rheumatology patients suggests information about COVID-19 vaccination will aid uptake Richard P Beesley, Wendy Costello, Saskya P Angevare, Carine Wouters, Nico Wulffraat, Yosef Uzie
208 [GO] 2021―Feb―05 Anti-PL-7 antisynthetase syndrome presenting as COVID-19 Tim Blake, Basil Noureldin
209 [GO] 2021―Feb―05 Remotely-delivered physiotherapy: can we capture the benefits beyond COVID-19? Lindsay M Bearne, William J Gregory, Michael V Hurley

211 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec